Nav: Home

Gaps in hepatitis testing and monitoring programmes across the EU/EEA

May 31, 2017

The survey results suggest a wide variation in existing national testing policy and practice when it comes to hepatitis B and C - with overall limited monitoring of testing, diagnosis, and treatment across EU/EEA Member States. Many respondents expressed a need for Europe-wide practical guidance on how testing initiatives should be conducted, evaluated, and monitored.

An estimated 9 to 10 million Europeans have been infected with the hepatitis B (HBV) or hepatitis C virus (HCV) in the countries of the European Union and European Economic Area (EU/EEA), and many are unaware of their infection. ECDC undertook two surveys to evaluate needs and priorities to inform a Guidance on HBV/HCV testing and screening in the EU and to assess the availability of monitoring data on the HBV and HCV epidemic against the core indicators defined in the WHO Regional Action Plan to eliminate viral hepatitis by 2030. 20 (65%) and 21 (68%) Member States responded to the two surveys.

The results suggest a wide variation in HBV/HCV testing policy and practice across the EU/EEA showing significant gaps in available testing guidance and a lack of national monitoring programmes regarding all aspects of testing, diagnosis, treatment, morbidity, and mortality.

Less than half of the responding EU/EEA countries have dedicated HBV or HCV testing guidance in place (29% and 48% respectively), with the remainder having either a number of policy documents where HBV/HCV is included, or no testing policy at all. Just more than half of the countries had a policy on testing of HBV/HCV among people who inject drugs in place, while other key groups such as commercial sex workers, me who have sex with men and people receiving tattoos or piercings in unregulated settings were mostly omitted.

A need for European-level guidance

At the implementation level, more than three out of four responding countries reported that they felt that risk groups were not targeted effectively by existing testing programmes. Just over half of responding countries agreed that there is a need for a new European-level testing guidance, in particular guidance on who to test, how to target those at risk, and monitoring and evaluation of testing initiatives.

With regards to monitoring indicators, almost all the responding countries collected some morbidity and mortality data on hepatitis B and C's long term complication, liver cancer.

However data on the HBV or HCV status of the patient was recorded by only a few. The most frequently monitored indicator for HCV was the number of people undergoing treatment (12 countries), whereas the number of those treated for HBV is only monitored in seven countries.

What is more: there are no indicators for hepatitis B or C infection that are monitored routinely by all responding Member States, meaning that further work would be required before any meaningful EU-wide monitoring can be established.

This baseline assessment on the situation in the EU/EEA, despite its limitations due to its the response rate, provides invaluable information towards the development of a planned ECDC Guidance on hepatitis testing helping to ensure that this new Guidance will focus on the main gaps identified.
-end-
Read the full report Hepatitis B and C testing activities, needs, and priorities in the EU/EEA

Read more

Systematic review on hepatitis B and C prevalence in the EU/EEA

Annual Epidemiological Report:

Hepatitis B - 2015 data for the EU/EEA

Hepatitis C - 2015 data for The EU/EEA

European Centre for Disease Prevention and Control (ECDC)

Related Hepatitis Articles:

Hepatitis C increasing among pregnant women
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.
WHO's Global Hepatitis Report sets baseline to eliminate viral hepatitis by 2030
The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO), which includes new data on the prevalence and global burden of viral hepatitis.
Elimination of viral hepatitis by 2030: What's needed and how do we get there?
This first European Action Plan provides an important driver to aid countries in their fight against viral hepatitis, to which ECDC had the opportunity to contribute directly.
Discovery of new Hepatitis C virus mechanism
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions.
Is Europe ready to eliminate viral hepatitis?
Currently, Europe records around 57,000 newly diagnosed acute and chronic cases of hepatitis B and C each year.
Why baby boomers need a hepatitis C screening
Hepatitis C affects a disproportionate amount of older Americans, born between 1945 and 1965.
Counterattack of the hepatitis B virus
The hepatitis B virus (HBV) infects liver cells. Drugs are available to treat HBV, but they rarely cure the infection, and so the virus typically returns after the treatment ends.
Hepatitis C tied to increased risk of Parkinson's
The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the Dec.
The hepatitis A virus is of animal origin
The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults.
Modeling the helicase to understand hepatitis C
NS3 is an enzyme specific to the hepatitis C virus.

Related Hepatitis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".